Nimotuzumab in Adults With Pancreatic Cancer

NCT00561990 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer, Advanced or Metastatic

Interventions

DRUG: Nimotuzumab

Sponsor

Oncoscience AG

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]